7,971 Shares in UnitedHealth Group Incorporated $UNH Acquired by Jackson Square Partners LLC

Jackson Square Partners LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 7,971 shares of the healthcare conglomerate’s stock, valued at approximately $2,487,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in the company. Bayforest Capital Ltd increased its stake in UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 48 shares during the last quarter. Clal Insurance Enterprises Holdings Ltd boosted its stake in UnitedHealth Group by 416.7% during the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock worth $32,000 after buying an additional 50 shares during the period. Glass Jacobson Investment Advisors llc raised its stake in shares of UnitedHealth Group by 80.9% in the 2nd quarter. Glass Jacobson Investment Advisors llc now owns 123 shares of the healthcare conglomerate’s stock valued at $38,000 after acquiring an additional 55 shares during the period. Kentucky Trust Co increased its holdings in UnitedHealth Group by 53.8% in the 2nd quarter. Kentucky Trust Co now owns 143 shares of the healthcare conglomerate’s stock valued at $45,000 after purchasing an additional 50 shares during the last quarter. Finally, Nova Wealth Management Inc. lifted its stake in UnitedHealth Group by 339.1% during the first quarter. Nova Wealth Management Inc. now owns 101 shares of the healthcare conglomerate’s stock worth $53,000 after purchasing an additional 78 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Wall Street Analysts Forecast Growth

UNH has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft lowered UnitedHealth Group from a “buy” rating to a “hold” rating and set a $333.00 target price for the company. in a report on Wednesday, October 29th. Oppenheimer decreased their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Baird R W downgraded shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research report on Thursday, July 31st. Royal Bank Of Canada upped their price objective on shares of UnitedHealth Group from $286.00 to $408.00 and gave the stock an “outperform” rating in a research report on Wednesday, October 29th. Finally, Morgan Stanley increased their price target on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a report on Friday, September 12th. Eighteen research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the stock. According to MarketBeat.com, UnitedHealth Group currently has an average rating of “Moderate Buy” and an average target price of $397.12.

UnitedHealth Group Price Performance

UNH opened at $324.29 on Friday. The company has a 50 day moving average of $345.84 and a two-hundred day moving average of $323.37. The company has a market cap of $293.75 billion, a P/E ratio of 16.93, a P/E/G ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last announced its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 EPS for the quarter, beating the consensus estimate of $2.87 by $0.05. The business had revenue of $113.16 billion for the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The company’s revenue was up 12.2% on a year-over-year basis. During the same period last year, the business posted $7.15 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be paid a dividend of $2.21 per share. The ex-dividend date of this dividend is Monday, December 8th. This represents a $8.84 annualized dividend and a yield of 2.7%. UnitedHealth Group’s payout ratio is 46.14%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.